Dual infection with Bordetella pertussis and Mycoplasma pneumoniae in three infants: case reports

A Zouari1, A Touati, H Smaoui

  • 1Laboratory of Microbiology, Children's Hospital of Tunis, Tunis, Tunisia. zouariasma1@yahoo.fr

Infection
|August 24, 2011
PubMed

Insights

Co-infection with Bordetella pertussis and Mycoplasma pneumoniae in infants can lead to severe respiratory illness. This study highlights the potential for fatal outcomes in mixed respiratory infections, emphasizing the need for comprehensive diagnostics.

Area of Science:

  • Pediatric Infectious Diseases
  • Respiratory Pathogen Research
  • Microbiology and Immunology

Background:

  • Pertussis-like symptoms in infants necessitate investigation into causative agents.
  • Co-infections with bacterial and atypical pathogens can complicate clinical presentation and outcomes.
  • Accurate diagnosis of respiratory infections is crucial for effective management.

Observation:

  • Three infant cases presented with concurrent Bordetella pertussis and Mycoplasma pneumoniae infections.
  • Bordetella pertussis was detected via real-time polymerase chain reaction (RT-PCR) in nasopharyngeal specimens.
  • Mycoplasma pneumoniae was identified through both culture and RT-PCR methods.

Findings:

  • Standard culture methods failed to isolate Bordetella pertussis or B. parapertussis from nasopharyngeal aspirates.
  • All three infants diagnosed with mixed Bordetella and Mycoplasma infections experienced fatal outcomes.
  • Real-time PCR proved effective in identifying Bordetella pertussis in these co-infected cases.

Implications:

  • Co-infection with other respiratory pathogens is likely common in Bordetella-infected patients.
  • Mixed infections may result in more severe disease presentations and increased mortality risk.
  • Diagnostic strategies should consider the possibility of co-infections for comprehensive patient care.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: